Description
Irinotecanisananalogofcamptothecinthatisusedclinicallytotreatcolonandovariancancers,amongothers.Irinotecanexhibitsanticancerchemotherapeutic,anti-angiogenic,andimmunosuppressiveactivities.IrinotecaninhibitsDNAtopoisomeraseIandsensitizestumorstotheeffectsofrADIation.Ingliomamodels,irinotecandecreasesthenumberoftumorvesselsanddecreasesexpressionofVEGFandHIF-1α,inhibitingtumorgrowth.Irinotecanalsomoderatesinhibitionofdendriticcelldifferentiationandmayproducecholinergicsideeffects,suggestingpotentialinhibitionofacetylcholinesterase(AChE)aswell.
References
HuJ,KinnJ,ZirakzadehAA,etal.Theeffectsofchemotherapeuticdrugsonhumanmonocyte-deriveddendriticcelldifferentiationandantigenpresentation.ClinExpImmunol.2013Jun;172(3):490-9.PMID:23600838.
PanP,LiY,YuH,etal.MolecularprincipleoftopotecanresistancebytopoisomeraseImutationsthroughmolecularmodelingapproaches.JChemInfModel.2013Apr22;53(4):997-1006.PMID:23521602.
ChenAY,ChenPM,ChenYJ.DNAtopoisomeraseIdrugsandradiotherapyforlungcancer.JThoracDis.2012Aug;4(4):390-7.PMID:22934142.
ChintalaS,TóthK,CaoS,etal.Se-methylselenocysteinesensitizeshypoxictumorcellstoirinotecanbytargetinghypoxia-inducIBLefactor1alpha.CancerChemotherPharmacol.2010Oct;66(5):899-911.PMID:20066420.
DoddsHM,RivoryLP.Themechanismfortheinhibitionofacetylcholinesterasesbyirinotecan(CPT-11).MolPharmacol.1999Dec;56(6):1346-53.PMID:10570064.